Digital Twin Calibration with Model-Based Reinforcement Learning

This study is motivated by optimal control applications that exhibit high complexity, high uncertainty, and very limited data [Wang et al., 2024, Zheng et al., 2023, Plotkin et al., 2017, Mirasol, 2017]. In particular, all of these challenges are present in the domain of biopharmaceutical manufacturing, used for production of essential life-saving treatments for severe and chronic diseases, including cancers, autoimmune disorders, metabolic diseases, genetic disorders, and infectious diseases such as COVID-19 [Zahavi and Weiner, 2020, Teo, 2022]. Using cells as factories, biomanufacturing involves hundreds of biological, physical, and chemical factors dynamically interacting with each other at molecular, cellular, and macroscopic levels and impacting production outcomes. Due to the complexity of these mechanisms, it is quite difficult to control production safely and effectively, especially in the presence of very limited data. Digital twins have proven very useful in guiding the control of complex physical systems [Tao et al., 2018].